Characterizing antibodies for studying immune cells in disease models
Official title: EAP-Derived Monoclonal Antibodies for Phenotyping Immune Cells of Animal Model of Disease
Funded at Silver Lake Research Corporation · NIH-10933282 · Data updated 2026-11-12
This study is working on creating special antibodies that can help scientists better understand how our immune system reacts to diseases and inflammation, which could lead to better ways to diagnose and treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Silver Lake Research Corporation NIH-funded |
| Lab location | 1 site (Azusa, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $750,000 |
| NIH project number | 75N93023C00039-0-9999-1 |
| Project ID | NIH-10933282 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would include individuals with immune-related disorders or those involved in related clinical studies.
✕Less likely to help
Patients with conditions unrelated to immune responses or those not participating in research settings may not receive any benefit from this research.
What this research studies
This research focuses on developing and characterizing monoclonal antibodies (mAbs) that target specific immune cell markers relevant to disease and inflammation. The project aims to assess the usability of these antibodies in various laboratory assays, create detailed protocols for their application, and ensure the production of high-quality reagents. By making these resources available to the research community, the study seeks to enhance the understanding of immune responses in disease models, potentially leading to improved diagnostic and therapeutic strategies.
Why it matters
Potential benefit: If successful, this research could provide valuable tools for better understanding and treating immune-related diseases.
How similar studies have gone: Previous research has shown success in using monoclonal antibodies for immune cell characterization, indicating a promising approach in this area.
Where this research is happening
-
Silver Lake Research Corporation
Azusa, United States Active
Researchers
- Principal investigator: Geisberg, Mark — Silver Lake Research Corporation
- Study coordinator: Geisberg, Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.